[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100477842":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Jules Bordet Institute","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Specific fatigue management program",null,[12],"Other: Ergospirometry",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Ergospirometry","Maximum aerobic capacity (VO2 max), Maximum load, Ventilatory threshold and the patient's RQ",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Laura Polastro, MD","CONTACT","+3225413279","laura.polastro@bordet.be",[25],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Institut Jules Bordet","RECRUITING","Brussels","1070","Belgium","BE",{"type":33,"coordinates":34},"Point",[35,36],4.34878,50.85045,{"lat":36,"lon":35},[39,41],{"name":20,"role":21,"phone":40,"phoneExt":10,"email":23},"+32 (0) 2 541 3279",{"name":42,"role":21,"phone":43,"phoneExt":10,"email":44},"Caroline Defays","+32 (0) 2 541 3966","caroline.defays@bordet.be",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100477842",false,"NCT05502224","Multidisciplinary Approach to Fatigue","Pilot Project for the Implementation of an Integrated Multidisciplinary Follow-up for Young Patients With Breast Cancer or Germ Cell Tumor","Inclusion Criteria:\n\n* Age between 18 and 39 years at the time of signing the informed consent\n* Patient who speaks and understands French\n* Signed study informed consent form obtained prior to any study related procedures\n* At minimum, a moderate (\\>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program\n* Patient with either: curative breast cancer (AJCC stage I-II-III) or a germ cell tumor\n\nExclusion Criteria:\n\n* Refusal to participate in the study\n* Patient having chosen to participate in another psychosocial intervention study for the duration of the study.\n* Patients with AJCC stage IV breast cancer","ALL","18 Years","39 Years",{"count":57,"type":58},50,"ESTIMATED","INTERVENTIONAL",[61],"NA","Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour",[64,65],"Breast Cancer","Germ Cell Tumor","2022-11-07",{"date":68,"type":69},"2022-11-08","ACTUAL",{"date":71,"type":69},"2022-08-19",{"date":73,"type":58},"2027-09",{"name":5,"class":6},1]